<sup>225</sup>Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic.

Pharmaceutics · 2023 · PMC10146019 · PMID 37111537

Europe PMC DOI

hedged sentence

0.3000

closest p · 6.0× alpha

0.3000

boldest claim

The sentences

did not reach statistical significancep = 0.3not close (p > 0.1)

8.5 months) than high-dose long-acting octreotide in advanced midgut GEP NET patients, although the OS endpoint of this study did not reach statistical significance (48 vs. 36.3 months, p = 0.3) [ 62 , 205 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.